24-hour hotline : 23 922 922
e-mail address : enquiry@tid.gov.hk
Ref. : 101-002-007
23 April 2025
Dear Sirs,
Commercial Information Circular No. 370/2025
The Mainland of China : “Application Materials and Technical Requirements for Hong Kong and Macao Registered Traditional Proprietary Chinese Medicines for Oral Use to be Registered in the Mainland under the Streamlined Approval Procedures”
The Center for Drug Evaluation of the National Medical Products Administration issued on 18 April 2025 the “Application Materials and Technical Requirements for Hong Kong and Macao Registered Traditional Proprietary Chinese Medicines for Oral Use to be Registered in the Mainland under the Streamlined Approval Procedures”, which took effect on the date of promulgation. Please refer to the Appendix for the notice (in Chinese only).
ENQUIRIES
2. If you have any questions on the content of the document mentioned in this circular, please contact the issuing authority of the Mainland. For other questions on this circular, please contact Mainland Branch (I) (tel: 2398 5444) of the Department.
Yours faithfully,
(Brian CHOI)
for Director-General of Trade and Industry
Note : While every effort is made to ensure the accuracy of the above information, the Department cannot guarantee this to be so and will not be held liable for any reliance placed on the same.